Daxor announces new distribution agreement with l1 enterprises government distributor

New york, jan. 13, 2021 (globe newswire) -- daxor corporation (nyse mkt: dxr), the global leader in blood volume measurement technology (organized as an investment company with fully-owned innovative medical instrumentation and biotechnology operations), announces today that it has signed a new distribution agreement with l1 enterprises, a leading provider of medical equipment and supplies to the government marketplace including the department of defense (dod), department of veterans affairs (va), health and human services (hhs) and the national institute of standards and technology (nist). daxor and l1 enterprises will work together to provide daxor's bva-100 (blood volume analysis) diagnostic blood test (“bva''), driving the use of bva to help guide precise, individualized volume management in a wide variety of medical conditions including heart failure and critical care.
DXR Ratings Summary
DXR Quant Ranking